Beyond Meat (BYND) investors should mark Nov. 11 on their calendars, as the plant-based meat company has pushed back its third-quarter earnings release by a week to address a significant accounting issue.
The delay comes as management requires additional time to calculate a material non-cash impairment charge related to certain long-lived assets. However, the company cannot yet reasonably quantify the amount.
The earnings postponement triggered an immediate market reaction, with shares plunging 16% on Monday. This setback occurs during an already turbulent period for Beyond Meat, which has recently experienced significant price swings that have captivated meme stock traders and short sellers alike.
Two weeks ago, Beyond Meat shares embarked on a remarkable rally, surging almost 150% in a single day, marking their best trading session ever. The explosive move followed the stock’s addition to the Roundhill Meme Stock ETF (MEME), which appeared to trigger a massive short squeeze as hedge funds scrambled to cover positions.
BYND stock continued to surge after Beyond Meat announced an expanded distribution partnership at Walmart (WMT) stores nationwide. BYND stock closed trading at $1.39 on Monday and was down over 7% in pre-market trading today. It is currently down about 0.4% in afternoon trading.
Beyond Meat faces serious fundamental challenges, having posted losses in each of the past five years. The stock has collapsed from its 2019 post-IPO high above $230 per share to a 52-week low of $0.50 in 2025.
Despite the recent rally, Beyond Meat stock is down 99% from its all-time high and has grossly underperformed the broader markets. Beyond Meat delivered deeply disappointing results in Q2, as it continues to struggle with a high cash burn rate and declining sales.
Beyond Meat reported revenue of $75 million in the June quarter, representing a 20% year-over-year (YoY) decline. The top line was well below management estimates and a sharp reversal from the marginal growth seen in late 2024.
Sales originating from the U.S. declined by 27% YoY, primarily due to premium pricing of products, slowing demand, and a challenging macroeconomic environment. Management also acknowledged that misinformation about product health benefits has become deeply ingrained and difficult to counter despite their efforts.
